Navigation Links
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Date:6/17/2010

WAYNE, N.J., June 17 /PRNewswire/ -- Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.  Cancer stem cells are a subset of tumor cells believed to play a significant role in the establishment, metastasis and recurrence of cancer and agents targeting the Wnt pathway have the potential to be developed as pan-tumor drugs.  The strategic alliance provides Bayer with the option to exclusively license antibody and protein therapeutic product candidates at any point up to the completion of Phase I testing.  In addition, Bayer and OncoMed will share technology and know-how to discover and develop small molecule inhibitors of the pathway.

"At Bayer, we recognize the high unmet medical need for cancer treatments.  This collaboration with OncoMed demonstrates our commitment to developing new and innovative treatment options," said Prof. Andreas Busch, Head of Global Drug Discovery and Member of the Board of Management at Bayer. "The development of anti-cancer stem cell therapeutics together with OncoMed is a highly innovative approach with the potential to perfectly complement our oncology portfolio.  Anti-cancer stem cell research could turn out as one of the missing pieces in today's cancer therapy."

"Our alliance with Bayer represents a major opportunity to discover and develop an entirely new class of anti-cancer stem cell therapeutics with one of the leading pharmaceutical companies in the world.  Bayer shares our vision for the potential of anti-cancer stem cell therapeutics, and we look forward to working closely with them," said Paul J. Hastings, President and CEO of
'/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Tevas Generic Oral Contraceptive Gianvi™
2. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
3. Bayer Diabetes Care Introduces DIDGET In the US
4. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
5. Bayers A1CNow(R) SELFCHECK At-Home A1C System Now Available In Local Pharmacies
6. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
7. Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels
8. Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced
9. Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
10. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
11. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... Mass. and JERUSALEM, Israel, Aug. 31, 2015 /PRNewswire/ ... late-stage biopharmaceutical company developing octreotide capsules for the ... the second quarter ended June 30, 2015 and ... few months have been a transformative time for ... offering and recently announced that our first New ...
(Date:8/31/2015)... Thousands of people will peacefully demonstrate their frustration with ... at dozens of rallies across the country today. Since ... United States has experienced skyrocketing rates of ... yet the President has never once spoken publicly about ... President Obama , rally organizers compared his failure to ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
... Reportlinker.com announces that a new ... its catalogue: A ... Lymphoma Pipeline: From Research and Development ... http://www.reportlinker.com/p0507256/A-Decision-Support-Tool-for-Optimizing-The-Lymphoma-Pipeline-From-Research-and-Development-to-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ...
... Calif., May 23, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... that management will present a general corporate update in conjunction ... on Thursday, June 16 at 2:15 p.m. Pacific Time in ... p.m. – 2:15 p.m. Annual Meeting of Stockholders (only for ...
Cached Medicine Technology:Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 2Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 3Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 4Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 5Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 6Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 7Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 8Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 9Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 10Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 11Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 12Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 13Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 14Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 15Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 16Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 17Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 18Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 19Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House 2
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... Agriculture ... just a few of the topics to be discussed at Seedstock’s 4th Annual Sustainable ... 3-4, 2015, at UC San Diego. , In addition to keynotes Pierre Sleiman, ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER ... now available. With the Connectivity Kit, EasySampler data is automatically transferred to, ... control experiment, on a touchscreen platform. , EasySampler fully automates the sampling ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... 1,500 investor-families have received permanent green cards (I-829 petition approval) from the USCIS ... petition is the final step of the EB-5 visa process for immigrant investors ...
(Date:9/1/2015)... Beach, FL (PRWEB) , ... September 01, 2015 ... ... pharmacy discount cards, launched its consumer-friendly, informational video this week to coincide with ... http://www.USAMedicalCard.com/video . , According to the CDC, elementary school children are ...
(Date:9/1/2015)... Vegas, NV (PRWEB) , ... September 01, 2015 ... ... care or Self-Directed Care is, how to access caregivers and what to look ... other valuable and pertinent information. , Founded in 2006 in Canoga Park, CA ...
Breaking Medicine News(10 mins):Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... Ont., October 13, 2010 A new material similar to ... is showing promise as the next novel treatment for bleeding ... cent of adults, according to Hong Kong physician Dr. James ... on this world-first research at the 23rd International Course on ...
... 2010--Many women have trouble finding time to exercise in their ... in northern climates such as Canada, where the weather can ... exercise is critical to managing gestational diabetes, a growing problem ... , Researchers at St. Michael,s Hospital have proposed a novel ...
... The Gerontological Society of America (GSA) and New America Media ... Foundation Journalists in Aging Fellows Program . They represent a wide ... Today , Sing Tao Daily , the Minneapolis Star ... GSA,s Annual Scientific Meeting scheduled for November 19 ...
... stimulation (DBS) has proven to be a lifeline for ... disorder that can cause lack of control over movement, ... The procedure is used only for ... A neurosurgeon uses magnetic resonance imaging or computed tomography ...
... , TUESDAY, Oct. 12 (HealthDay News) -- Many patients ... cancers, although these tests are unlikely to provide any ... York City have found. Specifically, many patients diagnosed ... are still undergoing the ordeal of routine breast, prostate ...
... 2010 Tenofovir gel, a vaginal microbicide that has shown ... in a new trial looking at its safety and acceptability ... by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials ... evaluated further for its potential to prevent HIV among both ...
Cached Medicine News:Health News:Hemostatic powder stops bleeding ulcers: Doctor 2Health News:Can Wii help control gestational diabetes? 2Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 2Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 3Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 4Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 5Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 6Health News:Researchers reach consensus on use of deep brain stimulation to treat Parkinson's 2Health News:Many With Terminal Cancer Still Getting Routine Screens 2Health News:Many With Terminal Cancer Still Getting Routine Screens 3Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 2Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 3Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: